シャーガス心筋症：治療薬の治験動向（2014年下半期）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Chagas Cardiomyopathy 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in North America 10
Top Countries Contributing to Clinical Trials in Central and South America 11
Clinical Trials by G7 Countries: Proportion of Chagas Cardiomyopathy to Cardiovascular Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Chagas Cardiomyopathy to Cardiovascular Clinical Trials 15
Clinical Trials in E7 Countries by Trial Status 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Unaccomplished Trials of Chagas Cardiomyopathy 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Drugs 24
Clinical Trial Overview of Top Institutes / Government 25
Universidade Federal de Minas Gerais 25
Clinical Trial Overview of Universidade Federal de Minas Gerais 25
Evandro Chagas Institute of Clinical Research 26
Clinical Trial Overview of Evandro Chagas Institute of Clinical Research 26
Ministerio da Saude, Brazil 27
Clinical Trial Overview of Ministerio da Saude, Brazil 27
Fundacion Cardiovascular de Colombia 28
Clinical Trial Overview of Fundacion Cardiovascular de Colombia 28
University Hospital Gottingen 29
Clinical Trial Overview of University Hospital Gottingen 29
Instituto do Coracao 30
Clinical Trial Overview of Instituto do Coracao 30
University of California, Los Angeles 31
Clinical Trial Overview of University of California, Los Angeles 31
The Hospital for Sick Children 32
Clinical Trial Overview of The Hospital for Sick Children 32
Johns Hopkins University 33
Clinical Trial Overview of Johns Hopkins University 33
National Heart, Lung, and Blood Institute 34
Clinical Trial Overview of National Heart, Lung, and Blood Institute 34
Five Key Clinical Profiles 35
Appendix 58
Abbreviations 58
Definitions 58
Research Methodology 59
Secondary Research 59
About GlobalData 60
Contact Us 60
Disclaimer 60
Source 60